Condition
Coronary Atherosclerosis of Native Coronary Artery clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Coronary Atherosclerosis of Native Coronary Artery clinical trials that are recruiting, at sites in 2 countries (most in Switzerland (1), United States (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Ziltivekimab to reduce coronary plaque after a heart attack
This study will test whether the anti-inflammatory drug ziltivekimab can reduce plaque buildup and improve plaque composition in people who recently had a heart attack and were treated with PCI.
-
Comparing PET/CT and Cardiac CT for Detecting Heart Disease
This study is testing if a new type of imaging called NaF-PET/CT can find heart disease better than the standard cardiac CT in patients showing symptoms of coronary artery disease.
Related topics
Quick answers
How many Coronary Atherosclerosis of Native Coronary Artery clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Switzerland (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.